Skip to main content
Hello! We use cookies to improve your experience by providing insights into how the site is being used. Find out more.

To: Roche Products Limited Pharmaceuticals and NICE (National Institute for Health and Care Excellence)

We need constructive dialogue regarding Kadcyla

We request both parties, Roche and NICE to engage in a constructive dialogue that enables the provision of Kadcyla to Breast Cancer Sufferers.

Why is this important?

This drug is a last resort for many people suffering from Breast Cancer, it provides a quality of life to sufferers who may be left with more aggressive forms of treatment. It can extend not only the quality of life but the length of time remaining to sufferers.

Sally Greenbrook from Breakthrough Breast Cancer said ' It is a brilliant drug but hugely expensive' ( BBC News 08/08/14)

More info here: http://www.bbc.co.uk/news/health-28688311

Category

Updates

2014-08-10 17:58:54 +0100

25 signatures reached

2014-08-10 11:24:51 +0100

10 signatures reached